Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism?

Affiliations

• ¹ Department of Health Sciences, University of Florence, viale Pieraccini, 6, Florence, 50139, Italy.
• ² Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
• ³ Division of Oncology, University Hospital 'Maggiore della Carità', Novara, Italy.
• ⁴ Oncology Unit, A.R.N.A.S. civico, Palermo Italy.
• ⁵ Department of Translational Medicine, University of Eastern Piedmont (UPO), Vercelli, VC, Italy.
• ⁶ Department of Health Sciences, University of Florence, Florence, Toscana, Italy.